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One of the major aspects of tumour cell invasion and metastasis is
the interaction between cancer cells and the surrounding extracel-
lular matrix (ECM). This interaction involves all the components
of the ECM, of which type I collagen is the most abundant and is
synthesized predominantly by fibroblasts. Some studies have
demonstrated that type I collagen may also be produced by epithe-
lial cells (Al-Adanani et al, 1975; Roesel et al, 1978; Sakakibara
et al, 1982; Liotta et al, 1983; Ohtani et al, 1992).
Collagen is involved in tumour progression in two very
different ways. The desmoplastic response to a tumour results in
excess deposition of collagen around the tumour. Conversely,
collagen degradation and decreased synthesis allow invasion of
tumour cells through the stroma. These processes may take place
concurrently (van der Hooff, 1988). Desmoplasia, the increased
deposition of stromal collagen, often results in the ‘hardening’ and
‘encapsulation’ of the tumour (Pucci-Minafra et al, 1986) and is
thought to be a host reaction to tumour cell invasion (Ohtani et al,
1992; Hewitt et al, 1993). It has been shown to occur in cancers
such as diffuse infiltrating gastric carcinomas and infiltrating
(scirrhous) carcinomas of the breast (Ohtani et al, 1992). In the
desmoplastic stroma of scirrhous breast carcinomas, collagen type
I is the most abundant protein (Barsky et al, 1982). The cause of
the desmoplasia is unknown and could be a response by the host in
order to isolate the tumour and prevent it from further growth and
possible invasion (Basset et al, 1990). Alternatively, the tumour
cells might secrete factors that induce desmoplasia, thereby
reducing access to the tumour by host lymphocytes, macrophages
and other immune regulators (Barsky and Gopalakrishna,
1987).
Degradation of the ECM is dependent on specific interactions
between tumour and host cells. Type I collagen, for example, is
degraded by interstitial collagenase or matrix metalloprotease-1
(MMP-1), which is produced by a number of cell types such as
tumour cells, fibroblasts, mast cells, leucocytes and macrophages
(Pauli et al, 1983; Biswas, 1984). Tumour cells can indirectly alter
the ECM by modulating fibroblast functions such as the secretion
of an extracellular matrix metalloproteinase-inducer (EMMPRIN),
which stimulates fibroblasts to produce collagenases (Biswas,
1982).
In this study, the relationship between type I collagen synthesis
and breast cancer stage was investigated. Type I collagen gene
expression was assessed in a number of normal and breast tumour
tissues by Northern analysis and RNA:RNA in situ hybridization
in order to determine whether there is a correlation between
tumour stage and collagen gene expression. In situ hybridization
analysis localized the a1(I) and a2(I) collagen mRNA to the
stromal fibroblasts adjacent to the tumour cells and not the tumour
cells in the breast carcinoma sections. Fibroblasts adjacent to stage
I tumours exhibited increased collagen mRNA levels compared to
the adjacent normal tissue, whereas in stage II and III tumours they
showed decreased mRNA levels. Furthermore, in vitro co-culture
of normal fibroblasts with breast tumour cell lines resulted in
down-regulation of collagen mRNA synthesis and protein produc-
tion by the fibroblasts. It would appear that the tumour cells and
fibroblasts need to be in close proximity in order for the down-
regulation of collagen mRNA to occur.
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Summary This study investigated the modulation of type I collagen gene expression in normal fibroblasts by breast tumour cells. Northern
analysis of total RNA extracted from stages I, II and III breast tumour tissue revealed that collagen mRNA levels were elevated in stage I
tumours compared to the adjacent normal breast tissues, whereas they were decreased in stages II and III breast tumours. This aberrant
collagen gene expression was confirmed by non-radioactive RNA:RNA in situ hybridization analysis of 30 breast carcinomas which localized
the production of type I collagen mRNA to the stromal fibroblasts within the vicinity of the tumour cells. In order to determine whether the
tumour cells were directly responsible for this altered collagen production by the adjacent fibroblasts, breast tumour cell lines were co-cultured
with normal fibroblasts for in vitro assessment of collagen and steady-state collagen RNA levels. Co-culture of tumour cells and normal
fibroblasts in the same dish resulted in down-regulation of collagen mRNA and protein. Treatment of the fibroblasts with tumour-cell
conditioned medium also resulted in decreased collagen protein levels but the mRNA levels, however, remained unaltered. These results
suggested that the tumour cells either secrete a labile ‘factor’, or express a cell surface protein requiring direct contact with the fibroblasts,
resulting in down-regulation of collagen gene expression. Modulation of the ECM is a common characteristic of invading tumour cells and
usually involves increased production of collagenases by the tumour cells or stromal fibroblasts. This study showed that tumour cells were
also able to modulate collagen mRNA production by stromal fibroblasts, which may facilitate tumour cell invasion and metastasis.
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These results suggest that the tumour cells are able to regulate
collagen production by the adjacent normal fibroblasts, either
directly or indirectly, resulting in decreased ECM production,
which would facilitate tumour cell invasion and subsequent metas-
tasis.
MATERIALS AND METHODS
Breast tumour tissue
Breast tumour tissue samples were collected from mastectomy
specimens in the theatre at Groote Schuur Hospital, Cape Town,
Republic of South Africa. The tumours were all of primary infil-
trating ductal type and samples were taken from the centre of the
tumour. Adjacent normal breast tissue, excised at a distance from
the tumour, was obtained from the same patient. The material was
divided, one half was immediately placed in liquid nitrogen and
stored at –70°C until further use, while the other half was
embedded in paraffin for pathological analysis.
Northern blot analysis
Breast tissue was homogenized on ice in guanidine isothiocyanate
solution after which the RNA was isolated as described by
Chomczynski and Sacchi (1987). Five micrograms of RNA were
electrophoresed on a 1% agarose gel containing 8% formaldehyde,
transferred to Hybond-N membranes which were then prehy-
bridized for 4 h at 42°C in 10% dextran sulphate, 5 ´ standard
saline citrate (SSC), 50 mM sodium pyrophosphate, 5 ´ Denhardts
solution, 50% formamide, 0.1 mg ml–1 herring sperm DNA and
0.1% sodium dodecyl sulphate (SDS).
a1(I) collagen cDNA (Chu et al, 1982), a2(I) collagen cDNA
(Myers et al, 1981) and pGEM b-actin probes were labelled with
32P-dCTP by nick translation (Amersham). Approximately 1 ´ 106
cpm ml–1 of denatured probe was added to the prehybridization
solution and the membranes were incubated overnight at 42°C.
The filters were washed twice for 15 min each at room tempera-
ture in 2 ´ SSC, 0.1% SDS followed by two washes for 15 min
each at 65°C in 0.1 ´ SSC, 0.1% SDS. Membranes were exposed
to X-ray film and quantitated by densitometry using the b-actin
signal as a control. All membranes were boiled in 0.1% SDS to
remove the hybridized probe for subsequent rehybridization to the
second probe.
RNA:RNA in situ hybridization
Paraffin-embedded primary infiltrating ductal carcinomas and
their adjacent normal tissue were cut into 5-mm sections using a
microtome and consecutive sections were applied to RNAase-free
slides previously coated with 5 mg ml–1 aminopropyltriethoxy-
silane. Sections were deparaffinized in xylene, rehydrated through
graded ethanols and finally phosphate-buttered saline (PBS). The
sections were treated with 1 mg ml–1 proteinase K in 10 mM
Tris–HCl (pH 7.5), 5 mM EDTA for 45 min at 37°C. After washing
in PBS, the sections were refixed in 0.4% paraformaldehyde,
acetylated in a 400:1 (v/v) solution of triethanolamine:acetic
anhydride for 10 min, rinsed in PBS, dehydrated in graded
ethanols and air-dried before hybridization. Sections were incu-
bated in a prehybridization mixture containing 25% dextran
sulphate, 25 mM Tris–HCl (pH 8.0), 2.5 ´ Denhardts solution,
2.5 mM EDTA, 25 mM dithiothreitol (DTT) 1.25 mg ml–1 herring
sperm DNA, 0.06 mg ml–1 tRNA and 50% deionized formamide
for 2 h at 50°C.
The hybridization probes were prepared as follows. A 160 base
pair XbaI-SacI fragment from HF32 (a2(I) collagen) and the 581
base pair EcoRI-SalI fragment from HF677 (a1(I) collagen) were
subcloned into pGEM3 (Promega). The 500 base pair fragment
from pGEMb-actin was released by digestion with PvuII and SalI
(Boehringer Mannheim). The appropriate fragments were excised
from the plasmids and used as templates to transcribe digoxi-
genin-labelled antisense RNA using T7 RNA polymerase
(Boehringer Mannheim). The vector sequences (pGEM3) were
used as a negative control to ensure that the hybridization signals
were specific.
In situ hybridization was performed as described by Hoefakker
et al (1995). Briefly, the digoxigenin-labelled riboprobe (5 ng ml–1)
was added to a hybridization mixture containing 20% dextran
sulphate, 12.5 mM Tris–HCl (pH 8.0), 2.5 ´ Denhardts solution,
2.5 mM EDTA, 2.5 mM DTT, 0.01 mg ml–1 herring sperm DNA,
0.002 mg ml–1 tRNA and 50% deionized formamide. The sections
were hybridized for 16–18 h at 50°C in a humidified chamber,
after which they were washed twice in 2 ´ SSC for 15 min each at
room temperature, followed by two washes in 0.1 ´ SSC at 43°C
for 15 min each. The sections were then incubated in 100 mM
Tris–HCl (pH 7.5), 150 mM sodium chloride for 5 min, blocked
with 2% normal sheep serum for 20 min at 37°C and washed in
0.05% Tween-20. Anti-digoxigenin antibody conjugated to alka-
line phosphatase (Boehringer Mannheim) was incubated with the
sections for 30 min at 37°C and the signal detected using NBT and
X-Phosphate as described by the manufacturers (Boehringer
Mannheim). Sections were dehydrated in ethanol, placed in
xylene, covered with a coverslip and viewed under a light micro-
scope.
Histopathological data
Infiltrating ductal carcinomas were staged according to the TNM
system where T is the tumour size, N is the number of lymph
nodes involved and M is the presence of distant metastases (Harris
et al, 1992). In this system, stage I tumours were < 2 cm, stage II
tumours were > 2 cm but < 5 cm and stage III tumours were > 5
cm. Histological data were determined by microscopic examina-
tion of haematoxylin and eosin-stained sections and staged inde-
pendently by two pathologists.
Cell culture
Normal breast tissue was cut into very fine pieces and placed in
30-mm sterile Petri dishes under a cover slip. The breast fibro-
blasts (BRF) were cultured in minimal essential medium
(MEM) containing 10% heat-inactivated fetal calf serum (FCS),
100 mg ml–1 penicillin and 100 units ml–1 streptomycin. WI-38
human lung fibroblasts, and the breast tumour epithelial cell lines
MDA-MB- 231, MCF-7, T47D and ZR-75-1 were also cultured in
the same medium.
Co-culture of normal fibroblasts and tumour cell lines
A mixture of 20 000 fibroblasts (BRF or WI-38) and 20 000
tumour cells (MDA-MB-231, MCF-7, T47D or ZR-75-1) were
seeded in 60-mm tissue culture dishes and incubated in MEM1144 G Fenhalls et al
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containing 10% FCS and the above antibiotics for 48 h prior to
harvesting for determination of collagen protein and mRNA
levels.
Collagen synthesis in fibroblasts cultured in tumour-
cell conditioned medium
Conditioned media were prepared from MDA-MB-231, T47D,
MCF-7 and ZR-75-1 breast cancer cell lines as described by
Biswas (1982). After 48 h of incubation the medium was removed,
the cell layers rinsed twice with PBS and serum-free MEM was
added. After 48 h the serum-free medium was removed and
centrifuged for 1 h to remove any cellular debris. The medium was
dialysed overnight at 4°C against distilled water, lyophilized,
reconstituted in one-tenth the original volume of sterile water and
sterilized by filtration.
Breast fibroblasts were plated at a density of 40 000 cells per
well in 24-well dishes and grown to 80% confluency. The cells
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n Figure 1 Northern blot analysis of RNA extracted from stages I, II and III
breast tumours and from the adjacent normal tissue. Total RNA was extracted
from breast tumours (T) and the adjacent normal (N) tissue of each patient
and hybridized with the nick-translated Hf32, full length a2(I) collagen cDNA
probe as described in Materials and Methods. The membranes were stripped
and re-hybridized with a nick translated b-actin cDNA probe, washed and
exposed to X-ray film for 24 h. A, C and E are autoradiographs from
representative Northern blots of total RNA from stage I, II and III tumours
respectively. Note that not all of the patient samples are shown. A summary
of the expression of a2(I) collagen mRNA relative to b actin mRNA from all
the patients with stages I, II and III tumours are shown in B, D and F
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were incubated in 1X conditioned medium at 37°C for 32 h and for
a further 16 h in the presence of 50 mg ml–1 ascorbate, 50 mg ml–1
b-aminopropionitrile and 10 mCi ml–1 3H-proline in order to label
the proteins prior to harvesting. Collagen was harvested from the
medium and quantitated using the collagenase assay as described
by Peterkofsky and Diegelmann (1974). The means and standard
deviations of three different experiments were calculated.
RESULTS
Northern blot analyses
Total RNA was extracted from 30 primary infiltrating ductal carci-
nomas and their adjacent normal tissues and probed for a1(I) and
a2(I) collagen mRNA by Northern blot analysis. The expression
of a2(I) collagen and b-actin mRNAs for several of the patients
are shown in Figure 1. Stage I breast carcinomas had increased
levels a2(I) collagen mRNA when compared to the adjacent
normal tissue (Figure 1 A,B). Stages II and III breast tumours,
however, had decreased a2(I) collagen mRNA levels when
compared to those in adjacent normal tissue (Figure 1 C–F).
Levels of a1(I) collagen mRNA were similar to those of the a2(I)
collagen mRNA (data not shown). All the results are expressed
relative to b-actin which was used to correct for any fluctuations in
RNA loading as well as to control for RNA degradation.
In situ hybridization analyses
In order to confirm the changes in collagen steady-state mRNA
levels detected by Northern blot analysis and to localize the cells
in which these changes occurred, breast tumour sections from each
of stages I, II and III and the corresponding adjacent normal tissue
were subjected to non-radioactive in situ hybridization (Figure 2).
Sections of a stage I tumour and the adjacent normal tissue were
hybridized with an a2(I) collagen riboprobe (Figure 2 A,B). The
normal tissue showed no histological abnormalities and was
characterized by intact mammary ducts (md), whereas the tumour
tissue contained fragmented collagen fibrils in the stroma and
numerous multinucleated tumour cells. The fibroblasts (indicated
by arrows) present in the stroma surrounding the tumour cells (t),
as well as those in the adjacent normal tissue, were positive for
a2(I) collagen mRNA, while the tumour cells themselves were
negative. Both the stromal fibroblasts and epithelial cells were
positive for b-actin in the normal and tumour tissue sections (data
not shown). These results demonstrated that the staining for
collagen mRNA was specific to the fibroblasts in the stroma and
not to the epithelial cells.
Sections of stage II tumour and normal tissue clearly showed
fibroblasts (arrows) lodged between the collagen fibrils (c) (Figure
2 C,D). A large number of fibroblasts were also located close to
the tumour cells. The fibroblasts present in the normal tissue adja-
cent to the tumour were positive for a2(I) collagen mRNA, while
those fibroblasts in the tumour were negative (indicated by an
arrow). The fibroblasts and tumour cells that were negative for
collagen mRNA were positive for b-actin mRNA (data not
shown). This indicated that those fibroblasts in the tumour tissue
were producing b-actin but not collagen mRNA.
Figure 2E and 2F show sections of a stage III tumour and the
adjacent normal tissue respectively. The stroma in the normal
tissue section was fairly intact, consisting of intact collagen fibrils
(c) and fibroblasts (arrows), while the tumour stroma (t) contained
infiltrating tumour cells and lymphocytes as well as fibroblasts. As
was shown for the stage II tumour above, the fibroblasts present
in the adjacent normal tissue were positive for a2(I) collagen
mRNA, while those in the tumour tissue were negative. Both the
fibroblasts and tumour cells were positive for b-actin mRNA (data
not shown).
A summary of results for 30 infiltrating breast carcinomas is
shown in Table 1. All ten stage I carcinomas exhibited increased
a1(I) and a2(I) collagen mRNA levels when compared to the
normal tissues, while stages II and III carcinomas had decreased
collagen gene expression. All tissue sections were probed with
pGEM3 riboprobe as a negative control and no signal was detected
indicating no non-specific binding of the riboprobes (data not
shown). Consecutive sections were also probed with an a1(I)
collagen riboprobe and similar results to those for a2(I) collagen
mRNA were obtained (data not shown).
In vitro co-culture of fibroblasts with breast tumour cell
lines
In order to determine whether the tumour cells affected collagen
gene expression in normal fibroblasts, various breast tumour cell
lines were co-cultured with normal human breast fibroblasts
(BRFs). The exact stage of these tumour cell lines are unknown
but they are probably derived from stage IV tumours (ATCC).
BRFs co-cultured with the breast tumour cell lines MDA-MB-231,
MCF-7, T47D and ZR-75-1 exhibited a greater than 50% decrease
(P < 0.05) in collagen protein as assessed by the collagenase assay
(Figure 3A). Since the breast tumour cells do not produce collagen
(data not shown) any contribution by these cells can be ignored.
The breast tumour cell lines were also co-cultured with WI-38
lung fibroblasts and a similar down-regulation of collagen
synthesis was observed (Figure 3B).
Total a2(I) collagen mRNA in co-cultures of WI-38 fibroblasts
and breast tumour cells was shown to be decreased (P < 0.05) as
assessed by Northern blot analysis (Figure 4). All samples were
corrected for cell number. These results indicated that the tumour
cells were responsible for modulating collagen gene expression in
the fibroblasts.
Culture of breast fibroblasts with conditioned medium
from breast tumour cell lines
In order to determine whether tumour cells secreted a stable
soluble factor(s) which was responsible for the down-regulation of
type I collagen gene expression, BRFs were incubated for 48 h
with conditioned medium prepared from the breast tumour cell
Table 1. Thirty tissue sections from stages I, II and III breast carcinomas
were analysed for collagen and b-actin gene expression by RNA:RNA in situ
hybridization
Tumour No. of Collagen gene b-actin gene
stage patients expression expression
I 10 +++ +++
II 10 – +++
III 10 – +++
Level of expression in fibroblasts in the tumour section was determined
visually and scored as either weaker (–) or stronger (+++) than fibroblasts in
the normal tissue sections.1146 G Fenhalls et al
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Stage I
Stage II
Stage III
Tumour Normal
A B
C D
E F
Figure 2 RNA:RNA in situ hybridization analysis of a2(I) collagen mRNA in stages I, II and III breast tumours and their adjacent normal tissues. Consecutive
sections of breast tumour explants were cut from a wax block and hybridized with the a2(I) collagen probe (A–F) or stained with haemotoxylin and eosin in
order to study the morphology (data not shown). The stage I tumour section (A) clearly shows the tumour cells (t) that have infiltrated the stroma containing
several stromal fibroblasts (arrows). The normal tissue (B) is characterized by normal mammary ducts (md) as well as intact collagen fibrils (c) with numerous
stromal fibroblasts (f). The stromal fibroblasts (arrows) in the tumour (A) were positive for a2(I) collagen mRNA (blue-purple staining of digoxigenin-labelling)
while the tumour cells (t) were not. Sections of a stage II breast carcinoma and the adjacent normal tissue are shown in C and D respectively. The tumour
section (C) contains tumour cells (t), which have infiltrated the stroma (c) and the fibroblasts (arrow) are negative for a2(I) collagen mRNA. The normal tissue
(D) shows intact collagen fibres (c) interspersed with fibroblasts staining positive for a2(I) collagen mRNA (arrows). Sections from a stage III breast tumour and
adjacent normal tissue are shown in E and F. The tumour tissue (E) consists mostly of tumour cells (t) and a region of intact stroma (s), containing a few
fibroblasts (arrow), next to the mammary duct (md) which is filled with tumour cells (t). The normal tissue shows intact collagen fibrils (c) with several fibroblasts
(arrow) as well as fragmented tissue (ft). Fibroblasts (arrow) in the normal tissue (F) stained positive for a2(I) collagen mRNA whereas the fibroblasts at the
periphery of the mammary duct in (E) were negative. Tumour cells were also negative. Total magnification for each section was 1003Down-regulation of type I collagen by breast tumour cells 1147
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lines and the levels of collagen protein and mRNA were deter-
mined.
Incubation of BRFs with tumour cell conditioned medium
resulted in decreased (P < 0.05) collagen protein levels (Figure
5A), whereas a2(I) collagen mRNA levels did not change signifi-
cantly (Figure 5B). Collagenase activity was found to be present in
the tumour cell conditioned media after co-culture with the fibro-
blasts (data not shown) which accounted for the discrepancy
between collagen protein and mRNA levels. Similar results were
found in studies by Biswas (1984).
These results suggested that, while collagenases induced by the
tumour cells were contributing to the decreased collagen protein
levels observed in fibroblasts cultured in tumour cell conditioned
media, the conditioned media alone could not induce down-
regulation of collagen mRNA observed in the co-culture of fibro-
blasts with tumour cells.
DISCUSSION
The Northern blot and in situ hybridization data on stages I, II and
III infiltrating ductal breast carcinomas indicated that tumour cells
can modulate type I collagen production. The elevation of type I
collagen mRNA levels in stage I breast tumours is most likely due
to the desmoplastic response (Noel et al, 1992). Breast tumours
which are associated with desmoplasia are sometimes known as
‘scirrhous carcinomas’ (Noel et al, 1992). The cause of the desmo-
plastic response remains unclear. One possible explanation for the
results presented in this study is that the excess collagen produc-
tion is a host defence in response to tumour cell invasion rather
than a tumour cell response for survival and growth.
There has been considerable controversy as to whether the
tumour cells themselves (Al-Adanani et al, 1975; Niitsu et al,
1988), or the fibroblasts in the vicinity of the tumour cells, are
stimulated to produce type I collagen (Barsky et al, 1982; Ohtani
et al, 1992; Hewitt et al, 1993). Early studies claimed that the
excess production of type I collagen is not due to increased
collagen synthesis by the stromal fibroblasts, but that it is
produced by the breast cancer cells themselves, which suggested
that this response was an inappropriate rather than a deliberate
host response (Al-Adanani et al, 1975). Subsequent studies have
shown that stromal fibroblasts do, in fact, produce the excess
collagen and that the epithelial cells are not responsible for the
desmoplastic effect (Barsky et al, 1982; Ohtani et al, 1992). The in
situ hybridization results presented in this study clearly demon-
strated that the host fibroblasts within the vicinity of the tumour
were responsible for the increased production of type I collagen
mRNA in the stage I breast carcinomas.
Nakanishi and co-workers (Nakanishi et al, 1994), using clones
of mouse Lewis lung carcinoma-derived cell lines with different
metastatic potentials, found an inverse relationship between the
host stromal response and spontaneous lung metastasis. These
results are similar to those reported in the present study where
collagen levels in stages I, and II/III are similar to those in the low
and high metastatic cells respectively. Our study found that the
fibroblasts were still present at the advanced stages of breast
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Figure 3 Synthesis of collagen in (A) breast fibroblasts (BRF) or (B) WI-38
lung fibroblasts co-cultured with breast tumour cell lines. Twenty thousand
BRF or WI-38 fibroblasts and 20 000 of the indicated breast tumour cell lines
MDA-MB-231 (MDA), MCF-7 (MCF), T47D and ZR-75-1 (ZR) were plated
onto 60 mm dishes and cultured for 32 h at which time 10 mCi ml–1 3H-proline,
50 mg ml–1 ascorbate a 50 mg ml–1 b-aminoproprionitrile was added in order to
label the collagen synthesized and the cells were further incubated for 16 h.
Collagen in the culture medium was quantitated using the collagenase assay
as described in Materials and Methods. Relative collagen production in co-
cultures was determined as a percentage of the collagen produced by BRF
or WI-38 cells cultured alone. Bars: standard error of the mean of three
separate experiments. Statistical significance was determined using an
unpaired Student’s t-test
Figure 4 Synthesis of collagen mRNA in WI-38 lung fibroblasts co-cultured
with tumour cells. Equal numbers of WI-38 fibroblasts and either MDA-MB-
231 (MDA), MCF-7 (MCF), T47D or ZR-75-1 (ZR) cells were co-cultured in
100 mm dishes for 48 h. Total RNA was isolated from co-cultures and
Northern blot analysis was carried out as described in Materials and
Methods. Relative collagen mRNA levels in co-cultures (after correction for
contributing cell number) was determined as a percentage of the collagen
mRNA in WI-38 cells cultured alone. Bars: standard error of the mean of
three separate experiments. Statistical significance was determined using an
unpaired Student’s t-test
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cancer, but that they were not producing collagen mRNA. While
Kauppila et al (1998) studied the expression of collagen in
different grades of breast tumour and found increased collagen
expression with increased de-differentiation, our study focused on
the stage of tumour which takes into account the biological quality
of tumour progression, growth and metastasis. The data presented
in this study suggest that desmoplasia is associated with the early
stages of the disease (stage I) and that collagen mRNA is down-
regulated in the later stages (II and III), which possibly facilitates
tumour cell invasion and eventual metastasis. This is in agreement
with the study by Hewitt and co-workers (Hewitt et al, 1993), who
reported the absence of type I collagen mRNA at the invasive edge
of colorectal tumours.
The in situ hybridization data suggested that the tumour cells
may be responsible for the observed down-regulation of collagen
mRNA in the adjacent fibroblasts since the fibroblasts in the direct
vicinity of the tumour cells exhibited decreased levels of collagen
mRNA. The other fibroblasts (as shown in the adjacent normal
sections of stage II and III tumours) were unaffected and continued
producing collagen mRNA. In vitro studies involving co-culture of
normal fibroblasts with several established breast tumour cell lines
supported this hypothesis. Co-culture of breast or lung fibroblasts
with tumour cells (which themselves do not produce collagen)
resulted in down-regulation of collagen protein and mRNA
production by the fibroblasts. These results indicated that the
tumour cells were down-regulating collagen production by the
adjacent fibroblasts.
Conditioned medium experiments suggest that the down-regula-
tion of collagen mRNA was not due to a soluble factor secreted by
the tumour cells, although it is possible that a factor is secreted in
very low concentrations by the tumour cells such that it may be
diluted in the conditioned media. Thus, only fibroblasts in the
vicinity of the tumour cells would respond to it as they do in the
co-culture experiments. The decrease in collagen protein, observed
in the conditioned medium experiments, may have been caused
partly by collagenases present in the conditioned medium after
co-culture with the fibroblasts (data not shown). The decrease in
collagen mRNA, however, probably involves a more complicated
mechanism. The most likely explanation is that the tumour cells
require either direct cell–cell contact with the fibroblasts, or need
to be in very close proximity to the fibroblasts in order to bring
about down-regulation of collagen mRNA. Direct cellular contact
would require that the tumour cells express a cell surface mole-
cule, which would bind a receptor on the fibroblasts leading to
down-regulation of collagen gene transcription via the signal
transduction pathway.
Alternatively, the tumour cells may secrete a factor, such as a
cytokine, at extremely low levels such that close proximity to the
target cell is required for binding to occur. The cytokines inter-
leukin (IL)-1b, tumour necrosis factor a (TNF-a) and trans-
forming growth factor b (TGF-b) exert their effects on type I
collagen synthesis in cultured Ito cells (lipocytes) via different
mechanisms. IL-1b acts at a post-transcriptional level to inhibit
collagen synthesis, TNF-a inhibits the transcription rate of the
proa1(I) collagen gene and TGF-b increases proa1(I) collagen
gene expression by increased transcription (Armendariz-Borunda
et al, 1992). These are therefore possible mechanisms, at least in
the case of IL-1b and TNF-a, by which collagen gene expression
could be down-regulated in the fibroblasts.
There are two general conclusions that can be drawn from this
study. First, that stromal fibroblasts, not the tumour cells, are
responsible for the overproduction of collagen in stage I breast
tumour tissue. Secondly, that tumour cells are able to induce
down-regulation of collagen mRNA production in fibroblasts in
advanced stage breast tumours by a mechanism yet to be eluci-
dated. The results suggest a novel way in which tumour cells can
modulate the extracellular matrix in order to facilitate invasion and
subsequent metastasis. We postulate that a physical interaction
exists between tumour cells and fibroblasts which is essential for
the observed down-regulation of collagen mRNA, and which,
either directly or indirectly, results in decreased ECM production
and ultimately disease progression.
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